Author: Snyder, E. E.; Kampanya, N.; Lu, J.; Nordberg, E. K.; Karur, H. R.; Shukla, M.; Soneja, J.; Tian, Y.; Xue, T.; Yoo, H.; Zhang, F.; Dharmanolla, C.; Dongre, N. V.; Gillespie, J. J.; Hamelius, J.; Hance, M.; Huntington, K. I.; Jukneliene, D.; Koziski, J.; Mackasmiel, L.; Mane, S. P.; Nguyen, V.; Purkayastha, A.; Shallom, J.; Yu, G.; Guo, Y.; Gabbard, J.; Hix, D.; Azad, A. F.; Baker, S. C.; Boyle, S. M.; Khudyakov, Y.; Meng, X. J.; Rupprecht, C.; Vinje, J.; Crasta, O. R.; Czar, M. J.; Dickerman, A.; Eckart, J. D.; Kenyon, R.; Will, R.; Setubal, J. C.; Sobral, B. W. S.
Title: PATRIC: The VBI PathoSystems Resource Integration Center Document date: 2006_11_16
ID: 3ulketgy_4
Snippet: The five categories of viruses studied by PATRIC are all positive-strand ssRNA viruses, with the exception of Lyssaviruses, which have negative-strand ssRNA genomes. While there are no reports of any of these viruses being weaponized, they represent the causative agents for a number of emerging and reemerging diseases including Severe Acute Respiratory Syndrome (SARS), rabies and transmissible gastroenteritis. Recombinant vaccines for these virus.....
Document: The five categories of viruses studied by PATRIC are all positive-strand ssRNA viruses, with the exception of Lyssaviruses, which have negative-strand ssRNA genomes. While there are no reports of any of these viruses being weaponized, they represent the causative agents for a number of emerging and reemerging diseases including Severe Acute Respiratory Syndrome (SARS), rabies and transmissible gastroenteritis. Recombinant vaccines for these viruses are either still in development or unavailable in areas where these infections are endemic or epidemic, compounding the public health risk.
Search related documents:
Co phrase search for related documents- causative agent and negative strand: 1
- causative agent and public health risk: 1, 2
- causative agent and recombinant vaccine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- causative agent and ssrna genome: 1
- causative agent and transmissible gastroenteritis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- causative agent and virus recombinant vaccine: 1, 2
- health risk and public health risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- negative strand and positive ssRNA strand: 1, 2, 3
- negative strand and ssrna genome: 1
- negative strand and ssRNA strand: 1, 2, 3, 4
- negative strand and transmissible gastroenteritis: 1, 2
- negative strand ssrna genome and ssrna genome: 1
- negative strand ssrna genome and ssRNA strand: 1
- positive ssRNA strand and ssrna genome: 1, 2, 3, 4
- positive ssRNA strand and ssRNA strand: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- positive ssRNA strand virus and ssrna genome: 1, 2
- positive ssRNA strand virus and ssRNA strand: 1, 2, 3, 4, 5
- recombinant vaccine and ssrna genome: 1
- recombinant vaccine and transmissible gastroenteritis: 1, 2, 3, 4, 5, 6, 7, 8
Co phrase search for related documents, hyperlinks ordered by date